IVOZALL

This brand name is authorized in Austria, Estonia, France, Ireland, Lithuania, Poland

Active ingredients

The drug IVOZALL contains one active pharmaceutical ingredient (API):

1 Clofarabine
UNII 762RDY0Y2H - CLOFARABINE

Clofarabine is a purine nucleoside anti-metabolite. Its antitumour activity is believed to be due to 3 mechanisms. Clofarabine produces DNA polymerase inhibition resulting in termination of DNA chain elongation and/or DNA synthesis/repair and ribonucleotide reductase inhibition with reduction of cellular deoxynucleotide triphosphate (dNTP) pools. Clofarabine also produces disruption of mitochondrial membrane integrity with the release of cytochrome C and other proapoptotic factors leading to programmed cell death even in non-dividing lymphocytes.

Read about Clofarabine

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
IVOZALL Concentrate for solution for infusion European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
L01BB06 Clofarabine L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01B Antimetabolites → L01BB Purine analogues
Discover more medicines within L01BB06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 1806612
Country: FR Base de données publique des médicaments Identifier(s): 65013013
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1088965
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100396940

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.